Symptomatic and Incidental RCC Detection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-01

Study Completion Date

2025-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the frequency of symptomatic and incidental detection of renal carcinoma at different stages depending on the imaging modality used

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Natural History of Small Renal Masses

NCT01305330

Patients With Newly Diagnosed Small Renal Masses(<4cm)

COMPLETED

Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy

NCT04309617

Renal Cell Carcinoma

COMPLETED

Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma

NCT04424472

Renal Cell Carcinoma

UNKNOWN NA

Translational Cancer Observational Protocol

NCT06169436

Upper Urinary Tract Urothelial Carcinoma

RECRUITING

TDM for Optimized Outcome in Patients With mRCC.

NCT04659343

Kidney Cancer Renal Cell Carcinoma Metastatic Drug Toxicity +2 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the Czech Republic, there is no screening program for renal cell carcinoma. Existing evidence suggests that incidental detection of this cancer tends to occur in its early stages, which are more manageable due to effective treatment options, ultimately reducing renal cancer mortality. This highlights the potential value of evaluating current imaging modalities and determining their role in secondary prevention. This cross-sectional study, based on hospital data, aims to contribute to a better understanding of this issue and to assess the effectiveness of imaging techniques in the early detection of renal cell carcinoma. Furthermore, data analysis may reveal the influence of risk factors on the detection of tumors at various stages.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Cell Carcinoma (Kidney Cancer) Benign Renal Neoplasm Renal Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A single patient group undergoing intervention for renal lesions

Surgical treatment of renal lesions

Intervention Type PROCEDURE

Surgical treatment of renal lesions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgical treatment of renal lesions

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients over 18 years of age undergoing surgical treatment for renal lesions

Exclusion Criteria

* patients undergoing surgery for non-renal and urotelial carcinoma, including unknown
* patients with recurrent renal lesions

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR